Now in its third year, the inVentiv Health (formerly Campbell Alliance) Dealmakers’ Intentions Survey is the only forward-looking measure of deal-making activity in the pharmaceutical and biotech industries. While there are many quality sources of information that look historically at past deal trends, this survey offers a prospective view of the partnering and licensing landscape for the year ahead.
For the first time, this year’s survey results represent input from all of the major pharmaceutical markets including:
61.1% of respondents from the United States
17.5% from Europe
11.1% from Canada
8.7% from Japan
1.6% from other regions
The survey results are split into four key areas, including Expectations and Intentions, Valuation, Organization and Process, and Strategic Implications. There were a number of interesting finding across all four of these areas.
Download a white paper summarizing the survey results. Results from prior Dealmakers' Intentions studies can be found in our Landmark Studies section.
Listen to a podcast summarizing the survey results, click.
Results from prior Dealmakers' Intentions studies can be found in our Landmark Studies section.